Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Versteeg

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Cell|July 27, 2010
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcomeMichael Hölzel, Sidong Huang, Jan Koster, et al.
Endocrine-Related Cancer|March 16, 2010
Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cellsCarla S Verissimo, Jan J Molenaar, John Meerman, et al.
The Journal of Molecular Diagnostics : JMD|January 19, 2012
Stability of PCR targets for monitoring minimal residual disease in neuroblastomaJanine Stutterheim, Lily Zappeij-Kannegieter, Ingrid Ora, et al.
Cancer Cell|April 7, 2009
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcomeSidong Huang, Jamila Laoukili, Mirjam T Epping, et al.
Clinical Chemistry|May 23, 2009
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markersJanine Stutterheim, Annemieke Gerritsen, Lily Zappeij-Kannegieter, et al.
Cancer Research|December 17, 2013
Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastomaEveline Barbieri, Katleen De Preter, Mario Capasso, et al.
Genes, Chromosomes & Cancer|August 31, 2002
Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patientsNadine Van Roy, Jo Vandesompele, Geert Berx, et al.
Nature Genetics|November 3, 2015
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumorsLinda J Valentijn, Jan Koster, Danny A Zwijnenburg, et al.
Oncogene|April 18, 2002
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2Marc B Godfried, Monique Veenstra, Peter v Sluis, et al.
Plos One|October 9, 2014
Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsamplingSangkyun Lee, Jörg Rahnenführer, Michel Lang, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Cell|July 27, 2010
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcomeMichael Hölzel, Sidong Huang, Jan Koster, et al.
Endocrine-Related Cancer|March 16, 2010
Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cellsCarla S Verissimo, Jan J Molenaar, John Meerman, et al.
The Journal of Molecular Diagnostics : JMD|January 19, 2012
Stability of PCR targets for monitoring minimal residual disease in neuroblastomaJanine Stutterheim, Lily Zappeij-Kannegieter, Ingrid Ora, et al.
Cancer Cell|April 7, 2009
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcomeSidong Huang, Jamila Laoukili, Mirjam T Epping, et al.
Clinical Chemistry|May 23, 2009
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markersJanine Stutterheim, Annemieke Gerritsen, Lily Zappeij-Kannegieter, et al.
Cancer Research|December 17, 2013
Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastomaEveline Barbieri, Katleen De Preter, Mario Capasso, et al.
Genes, Chromosomes & Cancer|August 31, 2002
Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patientsNadine Van Roy, Jo Vandesompele, Geert Berx, et al.
Nature Genetics|November 3, 2015
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumorsLinda J Valentijn, Jan Koster, Danny A Zwijnenburg, et al.
Oncogene|April 18, 2002
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2Marc B Godfried, Monique Veenstra, Peter v Sluis, et al.
Plos One|October 9, 2014
Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsamplingSangkyun Lee, Jörg Rahnenführer, Michel Lang, et al.
Pageof 14